See the DrugPatentWatch profile for fintepla

Cost-Saving Programs for Fintepla: A Guide for Patients and Prescribers

Fintepla, a medication used to treat seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome, can be a costly treatment option for many patients. However, there are several cost-saving programs available to help make Fintepla more affordable. In this article, we will explore these programs and provide guidance on how to access them.

What is Fintepla?

Fintepla (fenfluramine) is an oral medication approved by the FDA in 2020 for the treatment of seizures associated with LGS or Dravet syndrome. It works by reducing the frequency of seizures by targeting the brain's serotonin system.

Cost of Fintepla

Fintepla is a costly medication, with a monthly price tag of around $3,000 to $4,000. This can be a significant burden for many patients and their families, especially those with limited financial resources.

Cost-Saving Programs for Fintepla

Fortunately, there are several cost-saving programs available to help make Fintepla more affordable. Here are some options:

Patient Assistance Programs (PAPs)

PAPs are programs offered by pharmaceutical companies to provide free or low-cost medications to eligible patients. Fintepla's manufacturer, Marinus Pharmaceuticals, offers a PAP for patients who are uninsured or underinsured.

Co-pay Cards

Co-pay cards are programs that offer financial assistance to patients with commercial insurance. These cards can help reduce the out-of-pocket cost of Fintepla to as little as $5 per month.

Manufacturer-Sponsored Programs

Marinus Pharmaceuticals offers several manufacturer-sponsored programs to help make Fintepla more affordable. These programs include a co-pay card, a patient assistance program, and a medication assistance program.

Non-Profit Organizations

Several non-profit organizations, such as the Epilepsy Foundation, offer financial assistance to patients with epilepsy, including those taking Fintepla.

Discount Cards

Discount cards are programs that offer discounts on prescription medications, including Fintepla. These cards can be purchased online or through pharmacies.

How to Access Cost-Saving Programs

To access cost-saving programs for Fintepla, patients and prescribers can follow these steps:

1. Check eligibility: Check the eligibility criteria for each program to ensure you qualify.
2. Apply online: Apply online for the program that best fits your needs.
3. Contact the manufacturer: Contact Marinus Pharmaceuticals directly to inquire about their patient assistance program and other cost-saving options.
4. Consult with your prescriber: Consult with your prescriber to discuss your treatment options and any cost-saving programs that may be available.

Additional Resources

For more information on cost-saving programs for Fintepla, patients and prescribers can visit the following resources:

* DrugPatentWatch.com: A website that provides information on patent expiration dates and generic drug availability, which can help patients and prescribers make informed decisions about their treatment options.
* Marinus Pharmaceuticals: The manufacturer's website, which provides information on their patient assistance program and other cost-saving options.
* Epilepsy Foundation: A non-profit organization that provides financial assistance and support to patients with epilepsy.

Conclusion

Fintepla is a costly medication, but there are several cost-saving programs available to help make it more affordable. By understanding these programs and taking advantage of them, patients and prescribers can help reduce the financial burden of Fintepla and ensure that patients receive the treatment they need.

FAQs

1. Q: What is the cost of Fintepla?
A: The cost of Fintepla is around $3,000 to $4,000 per month.
2. Q: What are the cost-saving programs available for Fintepla?
A: The cost-saving programs available for Fintepla include patient assistance programs, co-pay cards, manufacturer-sponsored programs, non-profit organizations, and discount cards.
3. Q: How do I access cost-saving programs for Fintepla?
A: To access cost-saving programs for Fintepla, patients and prescribers can check eligibility, apply online, contact the manufacturer, and consult with their prescriber.
4. Q: What is the Epilepsy Foundation?
A: The Epilepsy Foundation is a non-profit organization that provides financial assistance and support to patients with epilepsy.
5. Q: What is DrugPatentWatch.com?
A: DrugPatentWatch.com is a website that provides information on patent expiration dates and generic drug availability, which can help patients and prescribers make informed decisions about their treatment options.

Cited Sources

1. Marinus Pharmaceuticals. (2020). Fintepla (fenfluramine) Prescribing Information.
2. DrugPatentWatch.com. (2022). Fintepla (fenfluramine) Patent Expiration Dates.
3. Epilepsy Foundation. (2022). Financial Assistance Programs.
4. Marinus Pharmaceuticals. (2022). Patient Assistance Program.
5. Fintepla.com. (2022). Co-pay Card Program.